Learn how molecular PCR testing can aid in the diagnosis of chronic skin and soft tissue infections and combat the limitations of culture to improve patient outcomes.
Viracor Eurofins utilizes a target enriched multiplex polymerase chain reaction technology to deliver a cutting-edge panel for bacterial infection identification for wounds:
Despite optimal specimen collection, culture bias and false negative results can be a real problem. Commensals may overgrow cultures and obscure the presence of pathogens. Some bacterial species will flourish under culture conditions, while others won't be detected. Biofilms, an ongoing issue for chronic wounds, are inherently polymicrobial. Culture can't identify these pathogens effectively.
In addition, culture cannot identify bacterial pathogens if the patient is undergoing antibiotic treatment.
Timing is critical when treating chronic wounds, both for the patient's well being and the costs they will incur. Molecular testing will help you identify which pathogens are present and deliver actionable information to help you decide the appropriate course of treatment.
Skin and Soft Tissue Infection Panel TEM-PCR™
Necrosis Panel TEM-PCR™
Connect with us